SCISPARC

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

#SimilarOrganizations #People #Financial #Website #More

SCISPARC

Industry:

Biotechnology Cannabis Medical

Founded:

2014-01-01

Address:

Giv'atayim, Tel Aviv, Israel

Country:

Israel

Website Url:

http://www.therapixbio.com

Total Employee:

11+

Status:

Active

Contact:

97236167055

Email Addresses:

[email protected]

Total Funding:

18.15 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL CPanel

Similar Organizations

alphamab-oncology-logo

Current Advisors List

not_available_image

Ran Nussbaum Chairman @ SciSparc
Board_member

Current Employees Featured

adi-zuloff-shani_image

Adi Zuloff-Shani
Adi Zuloff-Shani CTO @ SciSparc
CTO
2016-02-01

not_available_image

Ari Aminetzah
Ari Aminetzah CEO @ SciSparc
CEO

Stock Details

Company's stock symbol is NASDAQ:TRPX

Investments List

Date	Company	Article	Money raised
2022-03-31	MitoCareX Bio Ltd	SciSparc investment in Venture Round - MitoCareX Bio Ltd	700 K USD
2014-04-02	LaraPharm	SciSparc investment in Venture Round - LaraPharm	1.5 M USD

Official Site Inspections

http://www.therapixbio.com

Host Informations
Whois Informations

Loading ...